Global Interferons Market Size, Share, and Trends Analysis Report, By Product Type (Interferon Alpha, Interferon Beta, and Interferon Gamma), By Application (Hepatitis B, Hepatitis C, Melanoma, Leukemia, Multiple Sclerosis, and Renal Cell Carcinoma), (Forecast (2022-2028)

The global interferon market is anticipated to grow at a CAGR of 5.0% during the forecast period (2022- 2028). Interferons (IFNs) are a family of cytokines with the unique ability to induce cell-intrinsic programs that enhance resistance to viral infection. Interferons work through a range of mechanisms including cell growth inhibition, antiviral effects, and immune regulation. They have a high capacity for reproducing virus genomes and defending cells against viral infections. These advantages are supporting to drive the growth of the global interferon market. Additionally, antiviral activities of interferon such as immunoregulatory activities, anti-angiogenic, and cell growth inhibition are also expected to boost the growth of the market.

The market is segmented based on the service and application. Based on the service, the market is sub-segmented into interferon-alpha, interferon beta, and interferon gamma. Interferon-alpha is a cytokine produced by the innate immune system in response to environmental exposures including viral infections. Interferon-beta works by decreasing inflammation and preventing nerve damage that may cause symptoms of multiple sclerosis.  In multiple sclerosis, there is an occurrence of communication problems between the brain and the rest of the body. Interferon-gamma (IFN-γ) is a cytokine critical to both innate and adaptive immunity and functions as the primary activator of macrophages, additionally to stimulating natural killer cells and neutrophils. Interferon-beta (IFN-beta) is a polypeptide that is produced by fibroblasts and has antiproliferative and antiviral effects. For instance, in February 2021, Biogen Inc got the United States Food and Drug Administration (FDA) approval for a new intramuscular (IM) injection route of administration for PLEGRIDY (peginterferon beta-1a) for the treatment of relapsing forms of multiple sclerosis (MS).

Some major players in the market include Merck & Co., Inc., Biogen Inc., and Bayer AG, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in April 2021, Zydus Group received emergency use approval from the Drugs Controller General of India (DCGI) for the use of Pegylated Interferon alpha-2b, under brand Virafin in treating moderate COVID-19 infection in adults. Additionally, in April 2020, Bayer AG partnered with the Population Health Research Institute (PHRI) to launch a major clinical research program aimed at identifying potential treatments against COVID-19.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By  Product Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Competitive Landscape– Merck & Co., Inc., Biogen Inc., and Bayer AG, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?

Global Interferons Market Report by Segment

By Product Type

• Interferon Alpha
• Interferon Beta
• Interferon Gamma

By Application

• Hepatitis B
• Hepatitis C
• Melanoma
• Leukemia
• Multiple Sclerosis
• Renal Cell Carcinoma

Global Interferons Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa